Informations sur le produit
- 2,5-Dioxo-1-pyrrolidinyl 37-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-35-oxo-4,7,10,13,16,19,22,25,28,31-decaoxa-34-azaheptatriacontanoate
- 4,7,10,13,16,19,22,25,28,31-Decaoxa-34-azaheptatriacontanoic acid, 37-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-35-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
- 2,5-Dioxopyrrolidin-1-yl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28,31,34-decaoxa-4-azaheptatriacontan-37-oate
Mal-PEG10-NHS is a heterobifunctional PEG (polyethylene glycol) compound that is commonly used for pegylation, a process of covalently attaching PEG to biomolecules. It consists of a maleimide functional group and a N-hydroxysuccinimide (NHS) functional group, which allows for specific and stable conjugation with sulfhydryl groups (-SH) and primary amine groups (-NH2), respectively. Mal-PEG10-NHS is widely used in the development of PEG products for various applications in biotechnology and pharmaceutical industries. Its unique structure provides versatility in linking PEG to target molecules, enabling improved solubility, stability, and bioavailability. With its excellent reactivity and reliability, Mal-PEG10-NHS is an essential tool for researchers and scientists working on drug delivery systems, diagnostics, and other biomedical applications requiring precise pegylation.
